Aarti Drugs informs about disclosure

27 Dec 2022 Evaluate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, Aarti Drugs has informed that the Company has issued the Letter of Confirmation in lieu of Duplicate Share Certificate to the shareholder. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

455.75 -3.90 (-0.85%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.